The Cisplatin Injection, cataloged under National Stock Number 6505-01-314-4270, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Mead Johnson & Company, Llc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-314-4270 |
| Primary Part Number | NDC00015-3220-22 |
| Item Name | Cisplatin Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Mead Johnson & Company, Llc |
| Status | ACTIVE |
| Primary Container Content Quantity | 50.000 MILLILITERS |
| Primary Container Type | VIAL, SINGLE DOSE |
| Protective Storage Feature | ANTINEOPLASTIC DRUG |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| 3400957615772 | Accord Healthcare France SAS (FRA) |
| NDC00015-3220-22 PRIMARY | Mead Johnson & Company, Llc (USA) |
| Reference | Meaning |
|---|---|
| PLATINOL-AQ | 5/1 Secondary reference Mead Johnson & Company, Llc |
NSN 6505-01-314-4270 is a Cisplatin Injection, manufactured by Mead Johnson & Company, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-314-4270 has 2 manufacturer part numbers on file: 3400957615772 (Accord Healthcare France SAS), NDC00015-3220-22 (Mead Johnson & Company, Llc).
Key specifications for NDC00015-3220-22: Primary Container Content Quantity: 50.000 MILLILITERS; Primary Container Type: VIAL, SINGLE DOSE; Special Features: 50 MG CISPLATIN EQUIVALENT PREDILUTED IN 50 ML OF 0.9 PCT SODIUM CHLORIDE; STERILE; AQUEOUS; SINGLE-DOSE 50 ML FILL VIAL W/A RATED CAPACITY OF NOT LESS THAN 100 ML W/HANGING DEVICE WHICH ALLOWS THE BT TO BE HUNG FOR INTERMITTANT INTRAVENOUS ADMINISTRATION; FOR USE W/STOCKLISTED INTRAVENOUS INJECTION SETS; Protective Storage Feature: ANTINEOPLASTIC DRUG. 3 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.